As of Jun 29
| -0.81 / -4.12%|
The 4 analysts offering 12-month price forecasts for aTyr Pharma Inc have a median target of 42.00, with a high estimate of 44.00 and a low estimate of 32.00. The median estimate represents a +122.81% increase from the last price of 18.85.
The current consensus among 4 polled investment analysts is to Buy stock in aTyr Pharma Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.